CDK4 and breast cancer: In contrast to CDK4/6 inhibitor–mediated radiosensitization in breast cancer that is primarily mediated through suppression of HR, inhibition of other CDK proteins leads to increased apoptosis, senescence, and/or inhibition of RNA Polymerase II function that leads to radiosenstization (41–43).